Premium Industrial News

Novartis Investing Big in Austrian Generics Plant

Novartis Investing Big in Austrian Generics Plant

Novartis Investing Big in Austrian Generics Plant

Author: Martin Lynch | Published: August 07, 2020
Industry Segment: Pharmaceutical & Biotech  |  Word Count: 633 Words

GALWAY, IRELAND--August 11, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Novartis is to expand its Kundl antibiotics facility following a deal with the Austrian government that will see an investment of 150 million euro ($176 million).

Within this article: Details new plant investment, proposed works, antibiotics production in Europe, industry support for new antibiotics research

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?